Furazolidone- and nitrofurantoin-resistant Helicobacter pylori: Prevalence and role of genes involved in metronidazole resistance

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 1, 2001, Pages 306-308

  Kwon, D H ^a   Lee, M ^a   Kim, J J ^a   Kim, J G ^a   El Zaatari, F A K ^a   Osato, M S ^a   Graham, D Y ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FURAZOLIDONE; METRONIDAZOLE; NITROFURANTOIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; FEMALE; HELICOBACTER PYLORI; HUMAN; KNOCKOUT GENE; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; PREVALENCE; PRIORITY JOURNAL;

ANTI-INFECTIVE AGENTS, URINARY; ANTITRICHOMONAL AGENTS; DRUG RESISTANCE, MICROBIAL; FURAZOLIDONE; GENES, BACTERIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; METRONIDAZOLE; NITROFURANTOIN;

EID: 0035170308     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.1.306-308.2001     Document Type: Article

References (21)

1. Therapy of Helicobacter pylori infection
2. In-vitro evaluation of nitrofurantoin as an alternative agent for metronidaszole in combination antimicrobial therapy against Helicobacter pylori
3. Lymphoma of the gastrointestinal tract
4. The best therapy for Helicobacter pylori infection: Should efficacy or side-effect profile determine our choice?
5. Demonstration of unexpected antibiotic resistance of genotypically identical Helicobacter pylori isolates
6. Antimicrobial resistance in Helicobacter pylori: A global overview
7. Metronidazole-resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NAD(P)H nitroreductase
8. Choosing the best anti-Helicobacter pylori therapy: Effect of antimicrobial resistance
9. Furazolidone combination therapies for Helicobacter pylori infection in the United States
10. Helicobacter pylori porCDAB and oorDABC genes encode distinct pyruvate:flavodoxin and 2-oxoglutarate:acceptor oxidoreductases which mediate electron transport to NADP
11. Flavodoxin-dependent pyruvate oxidation, acetate production and metronidazole reduction by Helicobacter pylori
12. Analysis of an rdxA gene and involvement of additional genes encoding NADPH flavin oxidoreductase (FrxA) and ferredoxin-like protein (FdxB) in metronidazole resistance of Helicobacter pylori
13. Helicobacter pylori resistance to antibiotics
14. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil
15. Metronidazole and clarithromycin resistance amongst Helicobacter pylori isolates from a large metropolitan hospital in the United States
16. Helicobacter pylori
17. Helicobacter pylori: The size of the problem
18. Gastric, duodenal, and stress ulcer
19. Oxygen-insensitive nitroreductases: Analysis of the roles of nfsA and nfsB in development of resistance to 5-nitrofuran derivatives in Escherichia coli
20. High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and clarithromycin triple therapy for 1 week